Multiple Protective Roles of Nanoliposome-Incorporated Baicalein against Alpha-Synuclein Aggregates
Multiple Protective Roles of Nanoliposome-Incorporated Baicalein against Alpha-Synuclein Aggregates
复制标题
DOI:
10.1002/adfm.202007765
复制
发表时间:
2020-11-18
影响因子:
19
通讯作者:
Otzen, Daniel E.
中科院分区:
文献类型:
--
作者:
Aliakbari, Farhang;Mohammad-Beigi, Hossein;Otzen, Daniel E.
Nanoparticles are useful for increasing drug stability, solubility, and availability. The small molecule baicalein inhibits fibrillation, and detoxifies aggregates of alpha-synuclein (alpha SN) associated with Parkinson's disease (PD), but it suffers from instability, low solubility and consequent low availability. Here it is demonstrated that incorporation of baicalein into zwitterionic nanoliposomes (NLP-Ba) addresses these problems. NLP-Ba inhibits alpha SN fibril initiation, elongation, secondary nucleation, and also depolymerizes mature fibrils more effectively than free baicalein and prevents soluble alpha SN aggregates from seeding new fibrils. Importantly, NLP-Ba perturbs oligomers' capacity to permeabilize the membrane. The interaction between NLP-Ba and alpha SN is confirmed by different biophysical techniques. This nanosystem crosses the blood-brain barrier in vitro and is effective against rotenone neurotoxicity in vivo. The effect of NLP-Ba on alpha SN fibrillation/cytotoxicity is attributed to a combination of free baicalein and empty NLPs. The results indicate a neuroprotective role for NLP-Ba in decreasing alpha SN pathogenicity in PD and highlight the use of nanoliposomes to mobilize poorly soluble hydrophobic drugs.